STING Pathway Activation: Mechanistic Insights and Strate...

2025-10-17

Explore how small molecule STING pathway activators, exemplified by STING agonist-1, are reshaping translational immunology and oncology research. This thought-leadership article unpacks the mechanistic interplay between STING, CD40, and TRAF2 in B-cell-driven antitumor immunity—anchored in breakthrough findings from esophageal squamous cell carcinoma research—and offers strategic guidance for harnessing these insights in experimental and therapeutic development.